549
Participants
Start Date
March 31, 2016
Primary Completion Date
August 31, 2017
Study Completion Date
November 30, 2017
Oxycodone extended-release
Placebo of oxycodone extended-release
Site 243, New York
Site 261, Kew Gardens
Site 208, Williamsville
Site 233, Rochester
Site 279, Duncansville
Site 256, Jenkintown
Site 258, Lansdale
Site 249, Pikesville
Site 213, Winston-Salem
Site 242, Winston-Salem
Site 203, Charlotte
Site 251, Spartanburg
Site 205, Charleston
Site 247, Greenville
Site 212, Marietta
Site 223, Atlanta
Site 232, Port Orange
Site 270, Gainesville
Site 271, Winter Park
Site 211, Miami Beach
Site 229, Miami Beach
Site 278, Plantation
Site 227, Jupiter
SIte 204, Lake Worth
Site 214, Clearwater
Site 228, Bradenton
Site 264, Sarasota
Site 269, Inverness
Site 207, Birmingham
Site 202, Mobile
Site 244, Jackson
Site 276, Columbus
Site 240, Toledo
Site 209, Franklin
Site 259, Kettering
Site 222, Evansville
Site 210, Bay City
SIte 236, West Des Moines
Site 255, Chicago
Site 234, Hazelwood
Site 277, Overland Park
Site 265, Omaha
Site 206, New Orleans
Site 224, Shreveport
Site 239, Oklahoma City
Site 219, Richardson
Site 263, Hurst
Site 275, San Antonio
Site 218, Austin
Site 248, Boulder
Site 245, Boise
Site 253, Phoenix
Site 260, Phoenix
Site 268, Phoenix
Site 282, Tucson
Site 252, Albuquerque
Site 215, Long Beach
Site 220, La Mesa
Site 231, San Diego
Site 237, San Diego
Site 221, Wildomar
Site 235, Laguna Hills
Site 217, Anaheim
Site 280, Anaheim
Site 262, Napa
Site 201, Oakland
Site 238, Los Gatos
Site 225, Sacramento
Site 241, Everett
Site 257, Spokane
Site 226, Boston
Site 254, New Bedford
Site 266, Princeton
Site 267, Somerset
Lead Sponsor
Egalet Ltd
INDUSTRY